Dr. Abbey Doses First Patient in Phase III LUGANO Clinical Trial of Duravyu for Wet AMD
Texas Retina Associates Director of Clinical Research for Dallas Ashkan Abbey, MD, recently dosed the first patient in the Phase III LUGANO clinical trial of Duravyu (formerly EYP-1901) for the treatment of
read moreInflammatory Eye Disease Awareness Week
Prevent Blindness has declared September 16–22, 2024, as Inflammatory Eye Disease Awareness Week. There are several inflammatory eye conditions. The one we specialize in at Texas Retina is called uveitis [u-vee-i-tis]. Understanding
read moreDr. Wang Invited to Serve as Guest Lecturer at Ohio State University
Texas Retina’s Robert C. Wang will speak at The Ohio State University’s 7th Annual Retina Case Forum on Friday, August 16, 2024, as an invited guest lecturer. The event is a case-based
read moreDr. Wang Presented Initial Study Results of New Non-infectious Uveitis Treatment at ASRS 2024 Annual Meeting
Texas Retina’s Robert C. Wang, MD, presented “Safety and Efficacy of Brepocitinib, a TYK2/JAK1 Inhibitor, in Active Non-Infectious Uveitis: 24-Week Results from a 52-Week Phase II Study (NEPTUNE)” at the 2024 Annual
read moreDr. Anand and Dr. Abbey Receive Senior Honor Awards from the American Society of Retina Specialists (ASRS)
In recognition of their time and contributions to the scientific programs of the organization’s annual meetings, Texas Retina’s Rajiv Anand, MD, and Ashkan M. Abbey, MD, recently earned the Senior Honor Award
read moreDr. Wang Participated in Roundtable Discussion on XIPERE Treatment for Macular Edema Associated with Uveitis
At the most recent American Academy of Ophthalmology (AAO) Annual Meeting in Chicago, Texas Retina Associates’ Robert Wang, MD, participated in a roundtable discussion with seven other retina specialists to share their
read moreDr. Coors and Dr. Christopher Fuller Served as Invited Faculty for Retina LIVE! Surgical Case Series Event
Texas Retina Associates’ Lori E. Coors, MD, and Christopher G. Fuller, MD, joined speakers from Bascom Palmer Eye Institute, Stanford University’s Byers Eye Institute, and Duke University Eye Center as part of
read more